TLRY

Tilray Brands, Inc.

56
Fundamentals68/ 100
Valuation50/ 100
Upside potential63/ 100
Risk potential39/ 100

TLRY lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.

TLRY Fundamentals

MetricStatus
Healthy
Under pressure
Under pressure
Unavailable

TLRY's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

TLRY PE Valuation

TLRY has no meaningful PE right now: it lost money over the past year.

TLRY Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect TLRY's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

TLRY Risk to reward

ScenarioChangePrice
Upside+67%$4.17
Downside-39%$1.51

Calculated from the latest close: $2.49 on Nov 12.

TLRY's one-year upside scenario is somewhat larger than its downside: +67% against −39%.

TLRY Earnings Per Share

Q4 2023: $-22.80Q1 2024: $-5.00Q2 2024: $-3.30Q3 2024: $-2.70Q4 2024: $-3.00Q1 2025: $-10.50Q2 2025: $-24.60Q3 2025: $-24.20Q4 2025: $-23.61Q1 2026: $-15.15Q2 2026: $-1.09Q3 2026: $-1.41
Q4 2023: $-22.80Q1 2024: $-5.00Q2 2024: $-3.30Q3 2024: $-2.70Q4 2024: $-3.00Q1 2025: $-10.50Q2 2025: $-24.60Q3 2025: $-24.20Q4 2025: $-23.61Q1 2026: $-15.15Q2 2026: $-1.09Q3 2026: $-1.41
QuarterTTM EPSYoY
Q3 2026-$1.41+$22.79
Q2 2026-$1.09+$23.51
Q1 2026-$15.15-$4.65
Q4 2025-$23.61-$20.61
Q3 2025-$24.20-$21.50
Q2 2025-$24.60-$21.30
Q1 2025-$10.50-$5.50
Q4 2024-$3.00+$19.80

TLRY is still losing money, but far less than before: $1.41 per share over the past year, against $58.23 at its worst in mid-2020.

TLRY Quarterly Revenue

Q4 2023: $194MQ1 2024: $188MQ2 2024: $230MQ3 2024: $200MQ4 2024: $211MQ1 2025: $186MQ2 2025: $225MQ3 2025: $210MQ4 2025: $218MQ1 2026: $207MQ2 2026: $282MQ3 2026: $257M
Q4 2023: $194MQ1 2024: $188MQ2 2024: $230MQ3 2024: $200MQ4 2024: $211MQ1 2025: $186MQ2 2025: $225MQ3 2025: $210MQ4 2025: $218MQ1 2026: $207MQ2 2026: $282MQ3 2026: $257M
QuarterRevenueYoY
Q3 2026$257.1M+23%
Q2 2026$281.7M+25%
Q1 2026$206.7M+11%
Q4 2025$217.5M+3.1%
Q3 2025$209.5M+4.7%
Q2 2025$224.5M-2.3%
Q1 2025$185.8M-1.4%
Q4 2024$211M+8.9%

TLRY's revenue has grown year over year for five quarters in a row: $257M last quarter, up 23% from the same quarter a year ago.

TLRY Free Cash Flow

Q4 2023: −$36MQ1 2024: −$25MQ2 2024: $21MQ3 2024: −$42MQ4 2024: −$46MQ1 2025: −$20MQ2 2025: −$19MQ3 2025: −$1MQ4 2025: −$9MQ1 2026: −$22MQ2 2026: −$37MQ3 2026: −$17M
Q4 2023: −$36MQ1 2024: −$25MQ2 2024: $21MQ3 2024: −$42MQ4 2024: −$46MQ1 2025: −$20MQ2 2025: −$19MQ3 2025: −$1MQ4 2025: −$9MQ1 2026: −$22MQ2 2026: −$37MQ3 2026: −$17M
QuarterFree cash flowYoY
Q3 2026-$16.5M-$15.2M
Q2 2026-$37.3M-$18.2M
Q1 2026-$21.9M-$1.8M
Q4 2025-$8.5M+$37.6M
Q3 2025-$1.3M+$40.7M
Q2 2025-$19.1M-191%
Q1 2025-$20.2M+$4.7M
Q4 2024-$46.2M-$9.9M

TLRY has burned cash in almost every quarter: −$84M over the past year, against −$87M the year before.

TLRY Total Shares

Q4 2023: 73MQ1 2024: 75MQ2 2024: 74MQ3 2024: 88MQ4 2024: 86MQ1 2025: 91MQ2 2025: 89MQ3 2025: 106MQ4 2025: 110MQ1 2026: 113MQ2 2026: 112MQ3 2026: 133M
Q4 2023: 73MQ1 2024: 75MQ2 2024: 74MQ3 2024: 88MQ4 2024: 86MQ1 2025: 91MQ2 2025: 89MQ3 2025: 106MQ4 2025: 110MQ1 2026: 113MQ2 2026: 112MQ3 2026: 133M
PeriodChange %Net change
Quarterly+19%+21.5M shares
1 year+26%+27.3M shares
3 years+93%+64.2M shares
5 years+197%+88.4M shares
Available history+1484%+125M shares

TLRY has 133M diluted shares, up 26% from a year ago.

TLRY Net Leverage

TLRY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

TLRY Weekly Momentum

MetricValueStatus
RSI28.0Oversold
Stochastic6.8Oversold

TLRY's weekly RSI is 28 (oversold) and its Stochastic is 7 (oversold).

TLRY PE vs Healthcare Sector

TLRY has no meaningful PE right now: it lost money over the past year.

TLRY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.1320% below
20 week MA$3.9036% below
50 week MA$5.8958% below
100 week MA$7.3966% below
200 week MA$13.982% below

TLRY is in a downtrend: it's below all five of its weekly moving averages, and 82% below its 200-week average.

TLRY Yearly ROI

YearStart priceEnd priceROI
2020$162.8$85.9-47%
2021$85.9$78.4-8.7%
2022$78.4$27.9-64%
2023$27.9$23.0-18%
2024$23.0$14.3-38%
2025$14.3$9.60-33%
2026 YTD$9.60$2.49-74%

TLRY has finished every year since 2020 lower, and it's down 74% so far in 2026.

Give your agent the market.

Get API key